Menu

• Ask a Health Expert about GASTROINTESTINAL ANASTOMOTIC LEAK
• Post Your Side Effect related to GASTROINTESTINAL ANASTOMOTIC LEAK
• GASTROINTESTINAL ANASTOMOTIC LEAK and FDA Warnings
• GASTROINTESTINAL ANASTOMOTIC LEAK in Patients Wiki
• Report GASTROINTESTINAL ANASTOMOTIC LEAK in Drug Side Effect Survey

GASTROINTESTINAL ANASTOMOTIC LEAK side effect

What is GASTROINTESTINAL ANASTOMOTIC LEAK ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prostigminection Side Effects Report #5606116-6
Consumer or non-health professional from UNITED KINGDOM reported PROSTIGMINECTION problem on Nov 09, 2007. Female patient, 65 years of age, was diagnosed with neuromuscular blockade reversal and was treated with PROSTIGMINECTION. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal anastomotic leak, post procedural complication, shock, . PROSTIGMINECTION dosage: unknown. During the same period patient was treated with PICOLAX, MIDAZOLAM, PROPOFOL, ISOFLURANE. Patient was hospitalized. Patient recovered.

Reglan Side Effects Report #5485843-8
REGLAN problem was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Male patient, weighting 170.0 lb, was treated with REGLAN. After drug was administered, patient experienced the following problems/side effects: anal fistula, gastrointestinal anastomotic leak, lower gastrointestinal haemorrhage, rectal abscess, . REGLAN dosage: unknown. During the same period patient was treated with ZOFRAN, ATIVAN, PROCRIT, VICODIN, RADIATION, BEVACIZUMAB, FLUOROURACIL, LEUCOVORIN. Patient died on 08/26/2007.

Panitumumab Side Effects Report #5752583-7
Health Professional from UNITED STATES reported PANITUMUMAB problem on May 27, 2008. Male patient, 65 years of age, weighting 205.0 lb, was diagnosed with oesophageal carcinoma and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: empyema, gastrointestinal anastomotic leak, pleural effusion, post procedural complication, respiratory failure, . PANITUMUMAB dosage: PANITUMUMAB 349 MG IV; PANITUMUMAB 348 MG IV. During the same period patient was treated with OXALIPLATIN, XELODA. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5724869-3
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2008. Female patient, weighting 110.2 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: ascites, gastrointestinal anastomotic leak, haemoglobin decreased, intestinal obstruction, intra-abdominal haemorrhage, neuropathy peripheral, post procedural complication, retroperitoneal haemorrhage, . BEVACIZUMAB dosage: 508 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL, HYDROCLORATHIAZIDE, RAMIPRAL. Patient was hospitalized. Patient recovered.